The Klein Law Firm Reminds Investors of a Class Action Filed on Behalf of Puma Biotechnology, Inc. Shareholders & a Lead Plai...
June 13 2017 - 11:57AM
Business Wire
The Klein Law Firm announces that a class action complaint has
been filed on behalf of shareholders of Puma Biotechnology, Inc.
(NASDAQ:PBYI) who purchased shares between February 29, 2016 and May 4,
2017. The action, which was filed in the United States
District Court for the Central District of California, alleges that
the Company violated federal securities laws.
In particular, the complaint alleges that throughout the Class
Period, defendants made materially false and/or misleading
statements and/or failed to disclose that (i) the Company did not
anticipate that the U.S. Food and Drug Administration (“FDA”) would
ultimately approve PB272 (“neratinib”) for the treatment of breast
cancer; (ii) as such, Puma Biotechnology had overstated the drug’s
approval prospects and/or commercial viability; and (iii) as a
result, Puma Biotechnology’s public statements were materially
false and misleading at all relevant times.
Shareholders have until July 7, 2017 to petition the
court for lead plaintiff status. Your ability to share in any
recovery does not require that you serve as lead plaintiff. You may
choose to be an absent class member.
If you suffered a loss during the class period and wish to
obtain additional information, please contact Joseph Klein, Esq. by
telephone at 212-616-4899 or visit
http://www.kleinstocklaw.com/pslra-sa/puma-biotechnology-inc?wire=2.
Joseph Klein, Esq. is an experienced attorney and has also
practiced as a Certified Public Accountant. Mr. Klein represents
investors and participates in securities litigations involving
financial fraud throughout the nation. Attorney advertising. Prior
results do not guarantee similar outcomes.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170613006133/en/
The Klein Law FirmJoseph Klein, Esq., 212-616-4899Fax:
347-558-9665www.kleinstocklaw.com
Puma Biotechnology (NASDAQ:PBYI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Puma Biotechnology (NASDAQ:PBYI)
Historical Stock Chart
From Sep 2023 to Sep 2024